Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-06

Clinical Trial Update: Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of alogliptin used in combination with a sulfonylurea in adults with type 2 diabetes mellitus in J…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-07-06